Literature DB >> 9303419

Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: effects of complexation with copper(II), gallium(III), and iron (III) on their antiproliferative activities.

D R Richardson1.   

Abstract

This study examined if complexation with metals increased the antiproliferative activities of chelators of the pyridoxal isonicotinoyl hydrazone (PIH) class. Addition of iron(III) to some PIH analogs markedly depressed their activities, whereas it had little effect on others. The gallium(III) complex of PIH, but not its copper(II) complex, was more efficient than the apochelator at inhibiting [3H]thymidine incorporation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303419      PMCID: PMC164070          DOI: 10.1128/AAC.41.9.2061

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone.

Authors:  D R Richardson; K Milnes
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

2.  Deferoxamine inhibition of human neuroblastoma viability and proliferation.

Authors:  D L Becton; P Bryles
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

3.  Mechanism of inhibition of mammalian ribonucleotide reductase by the iron chelate of 1-formylisoquinoline thiosemicarbazone. Destruction of the tyrosine free radical of the enzyme in an oxygen-requiring reaction.

Authors:  L Thelander; A Gräslund
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

4.  The uptake of iron and transferrin by the human malignant melanoma cell.

Authors:  D R Richardson; E Baker
Journal:  Biochim Biophys Acta       Date:  1990-06-12

5.  Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA.

Authors:  R M Burger; J Peisach; S B Horwitz
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

6.  Cytotoxic effects of the lipophilic iron chelator omadine.

Authors:  G J Kontoghiorghes; A Piga; A V Hoffbrand
Journal:  FEBS Lett       Date:  1986-08-18       Impact factor: 4.124

7.  In vitro and in vivo effects of deferoxamine in neonatal acute leukemia.

Authors:  Z Estrov; A Tawa; X H Wang; I D Dubé; H Sulh; A Cohen; E W Gelfand; M H Freedman
Journal:  Blood       Date:  1987-03       Impact factor: 22.113

8.  Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II).

Authors:  D R Richardson; G T Hefter; P M May; J Webb; E Baker
Journal:  Biol Met       Date:  1989

9.  Colorimetric detection of the hydroxyl radical: comparison of the hydroxyl-radical-generating ability of various iron complexes.

Authors:  S Singh; R C Hider
Journal:  Anal Biochem       Date:  1988-05-15       Impact factor: 3.365

10.  Effects of a single course of deferoxamine in neuroblastoma patients.

Authors:  A Donfrancesco; G Deb; C Dominici; D Pileggi; M A Castello; L Helson
Journal:  Cancer Res       Date:  1990-08-15       Impact factor: 12.701

View more
  3 in total

1.  Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.

Authors:  Asikiya Walcourt; Joseph Kurantsin-Mills; John Kwagyan; Babafemi B Adenuga; Danuta S Kalinowski; David B Lovejoy; Darius J R Lane; Des R Richardson
Journal:  J Inorg Biochem       Date:  2013-08-26       Impact factor: 4.155

2.  Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation.

Authors:  M Hermes-Lima; M S Gonçalves; R G Andrade
Journal:  Mol Cell Biochem       Date:  2001-12       Impact factor: 3.396

3.  Gallium (III) Complexes with 5-Bromosalicylaldehyde Benzoylhydrazones: In Silico Studies and In Vitro Cytotoxic Activity.

Authors:  Boryana Nikolova-Mladenova; Silvia Angelova; Georgi Momekov
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.